Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 29, 2025	Dec. 31, 2024
Current Assets
Cash and cash equivalents	$ 30,732	$ 37,139
Accounts receivable, net of allowance for credit losses of $2,122 and $2,630 at March 29, 2025 and December 31, 2024, respectively	119,154	109,716
Contract assets	210,897	200,584
Inventories	197,414	196,881
Production cost of contracts	6,699	6,802
Other current assets	13,641	16,959
Total Current Assets	578,537	568,081
Property and Equipment, Net of Accumulated Depreciation of $197,524 and $194,921 at March 29, 2025 and December 31, 2024, respectively	109,075	109,812
Operating Lease Right-of-Use Assets	26,423	28,611
Goodwill	244,600	244,600
Intangibles, Net	145,403	149,591
Deferred Income Taxes	4,245	2,239
Other Assets	20,332	23,167
Total Assets	1,128,615	1,126,101
Current Liabilities
Accounts payable	80,290	75,784
Contract liabilities	37,496	34,445
Accrued and other liabilities	34,365	44,214
Operating lease liabilities	8,721	8,531
Current portion of long-term debt	12,500	12,500
Total Current Liabilities	173,372	175,474
Long-Term Debt, Less Current Portion	229,920	229,830
Non-Current Operating Lease Liabilities	19,103	21,284
Other Long-Term Liabilities	13,213	16,983
Total Liabilities	435,608	443,571
Commitments and Contingencies (Notes 8, 10)
Shareholders’ Equity
Common Stock - $0.01 par value; 35,000,000 shares authorized; 14,868,305 and 14,781,218 shares issued and outstanding at March 29, 2025 and December 31, 2024, respectively	149	148
Additional Paid-In Capital	219,842	217,523
Retained Earnings	463,986	453,475
Accumulated Other Comprehensive Income	9,030	11,384
Total Shareholders’ Equity	693,007	682,530
Total Liabilities and Shareholders’ Equity	$ 1,128,615	$ 1,126,101